---
title: "QUAN LUCINDA Y. — Ownership Dossier"
canonical: https://whiteintel.dev/entity/100e9f77-3468-56a7-97c3-ebbf424b538d
json: https://whiteintel.dev/api/public/dossier/100e9f77-3468-56a7-97c3-ebbf424b538d
identifier: sec:0001824711
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# QUAN LUCINDA Y.

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001824711`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/100e9f77-3468-56a7-97c3-ebbf424b538d  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/100e9f77-3468-56a7-97c3-ebbf424b538d  

## Ownership & control

### Holdings / subsidiaries

- **Aligos Therapeutics, Inc.** (officer) — https://whiteintel.dev/entity/15206969-c284-5758-b9c6-6d6ff804a67a

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **QUAN LUCINDA Y.**. Human view: https://whiteintel.dev/entity/100e9f77-3468-56a7-97c3-ebbf424b538d · Structured JSON: https://whiteintel.dev/api/public/dossier/100e9f77-3468-56a7-97c3-ebbf424b538d._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._